https://orcid.org/0000-0002-5544-4958
Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Daniel S. Lefler, Steven A. Manobianco & Babar Bashir. (2024) Immunotherapy resistance in solid tumors: mechanisms and potential solutions. Cancer Biology & Therapy 25:1.
Read now
Read now
Articles from other publishers (24)
Ruud H. Wijdeven, Sietse J. Luk, Tom A. W. Schoufour, Sabina Y. van der Zanden, Marta Cabezuelo, Mirjam H. M. Heemskerk & Jacques Neefjes. (2024) Balanced Epigenetic Regulation of MHC Class I Expression in Tumor Cells by the Histone Ubiquitin Modifiers BAP1 and PCGF1. The Journal of Immunology 212:3, pages 446-454.
Crossref
Crossref
Ayse Caner. (2023) Immune Escape Mechanism of Cancer. Current Molecular Biology Reports 10:1, pages 9-19.
Crossref
Crossref
Galaxia M. Rodriguez, Edward Yakubovich & Barbara C. Vanderhyden. (2023) Unveiling the Immunogenicity of Ovarian Tumors as the Crucial Catalyst for Therapeutic Success. Cancers 15:23, pages 5694.
Crossref
Crossref
Gulce Sari & Kenneth L Rock. (2023) Tumor immune evasion through loss of MHC class-I antigen presentation. Current Opinion in Immunology 83, pages 102329.
Crossref
Crossref
Susann Stephan-Falkenau, Anna Streubel, Thomas Mairinger, Torsten-Gerriet Blum, Jens Kollmeier, Fabian D. Mairinger, Torsten Bauer, Joachim Pfannschmidt, Manuel Hollmann & Michael Wessolly. (2023) Integrated Clinical, Molecular and Immunological Characterization of Pulmonary Sarcomatoid Carcinomas Reveals an Immune Escape Mechanism That May Influence Therapeutic Strategies. International Journal of Molecular Sciences 24:13, pages 10558.
Crossref
Crossref
Yuan Wang, Simon Jasinski-Bergner, Claudia WickenhauserBarbara Seliger. (2023) Cancer Immunology: Immune Escape of Tumors—Expression and Regulation of HLA Class I Molecules and Its Role in Immunotherapies. Advances in Anatomic Pathology 30:3, pages 148-159.
Crossref
Crossref
Zuhu Yu, Chong Lu, Bin Lu, Hong Gao, Rongfang Liang & Wuxing Xiang. (2023) A novel prognostic signature for clear cell renal cell carcinoma constructed using necroptosis-related miRNAs. BMC Genomics 24:1.
Crossref
Crossref
Agata Poniewierska-Baran, Łukasz Zadroga, Edo Danilyan, Paulina Małkowska, Paulina Niedźwiedzka-Rystwej & Andrzej Pawlik. (2023) MicroRNA as a Diagnostic Tool, Therapeutic Target and Potential Biomarker in Cutaneous Malignant Melanoma Detection—Narrative Review. International Journal of Molecular Sciences 24:6, pages 5386.
Crossref
Crossref
Antonino A. Pane, Theresa Kordaß, Agnes Hotz‐Wagenblatt, Elke Dickes, Annette Kopp‐Schneider, Rainer Will, Barbara Seliger, Wolfram Osen & Stefan B. Eichmüller. (2023)
MicroRNAs affecting the susceptibility of melanoma cells to CD8
+
T cell‐mediated cytolysis
. Clinical and Translational Medicine 13:2.
Crossref
Crossref
Fernanda Silva Medeiros, Mauro César da Silva, Neila Caroline Henrique da Silva, Thailany Thays Gomes, Renan Garcia Gomes, Larissa Albuquerque Paiva, Fabiana Oliveira dos Santos Gomes, Christina Alves Peixoto, Maria Carolina Valença Rygaard, Stefan Welkovic, Maria Luiza Bezerra Menezes, Eduardo Antônio Donadi & Norma Lucena-Silva. (2022) The antigen processing-associated transporter gene polymorphism: Role on gene and protein expression in HPV-infected pre-cancerous cervical lesion. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Crossref
Liren Jiang, Siteng Chen, Qi Pan, Jun Zheng, Jin He, Juanjuan Sun, Yaqin Han, Jiji Yang, Ning Zhang, Guohui Fu & Feng Gao. (2022) The feasibility of proteomics sequencing based immune-related prognostic signature for predicting clinical outcomes of bladder cancer patients. BMC Cancer 22:1.
Crossref
Crossref
Shruti Sethi, Poonam Mehta, Aastha Pandey, Gopal Gupta & Singh Rajender. (2022) miRNA Profiling of Major Testicular Germ Cells Identifies Stage-Specific Regulators of Spermatogenesis. Reproductive Sciences 29:12, pages 3477-3493.
Crossref
Crossref
Linyinxue Dong, Xuechen Tian, Yunqi Zhao, Haohong Tu, Aloysius Wong & Yixin Yang. (2022) The Roles of MiRNAs (MicroRNAs) in Melanoma Immunotherapy. International Journal of Molecular Sciences 23:23, pages 14775.
Crossref
Crossref
William W. Tang, Kaylyn M. Bauer, Cindy Barba, Huseyin Atakan Ekiz & Ryan M. O’Connell. (2022) miR-aculous new avenues for cancer immunotherapy. Frontiers in Immunology 13.
Crossref
Crossref
Wen Q. HUANG, Qian R. ZHUANG & Zhi J. HE. (2022) ILF3-AS1 promotes the aerobic glycolysis and proliferation of melanoma cells by regulating miR-493-5p/PDK1 pathway. Italian Journal of Dermatology and Venereology 157:2.
Crossref
Crossref
Brandie C. Taylor & Justin M. Balko. (2022) Mechanisms of MHC-I Downregulation and Role in Immunotherapy Response. Frontiers in Immunology 13.
Crossref
Crossref
Xiaoxue Li, Shiyu Zeng, Yiling Ding, Yanting Nie & Mengyuan Yang. (2021) Comprehensive Analysis of the Potential Immune-Related Biomarker Transporter Associated With Antigen Processing 1 That Inhibits Metastasis and Invasion of Ovarian Cancer Cells. Frontiers in Molecular Biosciences 8.
Crossref
Crossref
Mai-Huong Thi Nguyen, Yueh-Hsia Luo, An-Lun Li, Jen-Chieh Tsai, Kun-Lin Wu, Pei-Jung Chung & Nianhan Ma. (2021) miRNA as a Modulator of Immunotherapy and Immune Response in Melanoma. Biomolecules 11:11, pages 1648.
Crossref
Crossref
Marcus Bauer, Simon Jasinski-Bergner, Ofer Mandelboim, Claudia Wickenhauser & Barbara Seliger. (2021) Epstein–Barr Virus—Associated Malignancies and Immune Escape: The Role of the Tumor Microenvironment and Tumor Cell Evasion Strategies. Cancers 13:20, pages 5189.
Crossref
Crossref
Noémie Joalland, Kathleen Ducoin, Gwenann Cadiou, Catherine Rabu & Carole Guillonneau. (2021) 24th “Nantes Actualités en Transplantation” and 4th “LabEx Immunotherapy-Graft-Oncology” NAT and IGO Joint Meeting “New Horizons in Immunotherapy”. Frontiers in Immunology 12.
Crossref
Crossref
Ahmet Hazini, Kerry Fisher & Len Seymour. (2021) Deregulation of HLA-I in cancer and its central importance for immunotherapy. Journal for ImmunoTherapy of Cancer 9:8, pages e002899.
Crossref
Crossref
M.L.M. Jongsma, J. Neefjes & R.M. Spaapen. (2021) Playing hide and seek: Tumor cells in control of MHC class I antigen presentation. Molecular Immunology 136, pages 36-44.
Crossref
Crossref
Barbara Seliger & Chiara Massa. (2021) Immune Therapy Resistance and Immune Escape of Tumors. Cancers 13:3, pages 551.
Crossref
Crossref
Maria-Filothei Lazaridou, Chiara Massa, Diana Handke, Anja Mueller, Michael Friedrich, Karthikeyan Subbarayan, Sandy Tretbar, Reinhard Dummer, Peter Koelblinger & Barbara Seliger. (2020) Identification of microRNAs Targeting the Transporter Associated with Antigen Processing TAP1 in Melanoma. Journal of Clinical Medicine 9:9, pages 2690.
Crossref
Crossref